Jeffrey Stein's Net Worth
-$817 Thousand
Who is Jeffrey Stein?
Jeffrey Stein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Trius Therapeutics Inc, IDEAYA Biosciences, Inc., Cidara Therapeutics, Inc., and Paratek Pharmaceuticals, Inc..
SEC CIK
Jeffrey Stein's CIK is 0001478831
Past Insider Trading and Trends
2021 was Jeffrey Stein's most active year for acquiring shares with 9 total transactions. Jeffrey Stein's most active month to acquire stocks was the month of February. 2023 was Jeffrey Stein's most active year for disposing of shares, totalling 10 transactions. Jeffrey Stein's most active month to dispose stocks was the month of August. 2018 saw Jeffrey Stein paying a total of $1,031,250.20 for 714,885 shares, this is the most they've acquired in one year. In 2013 Jeffrey Stein cashed out on 1,204,526 shares for a total of $9,549,668.09, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trius Therapeutics Inc No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -210.46K |
—
|
—
|
0
|
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
| +22.36% | 38.46K |
$0.52 | $20,000.24 | 210.46K |
Mar 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +15.20% | 22.7K |
$0.52 | $11,804.00 | 172K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 3
| |||
Form 4
| +3.67% | 5.29K |
—
|
—
| 149.29K |
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDEAYA Biosciences, Inc. (IDYA) Snapshot price: $43.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cidara Therapeutics, Inc. (CDTX) Snapshot price: $0.6601
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| -4.68% | -56.69K |
$0.69 | -$39,117.48 | 1.15M |
Mar 11
| |||
Form 4
| +17.76% | 50K |
$0.96 | $47,885.00 | 331.6K |
Aug 8
| |||
Form 4
| +29.20% | 271.75K |
—
|
—
| 1.2M |
Mar 27
| |||
Form 4
| +21.59% | 50K |
$1.04 | $51,855.00 | 281.6K |
Mar 27
| |||
Form 4
| +88.34% | 432.76K |
$0.83 | -$117,017.55 | 922.63K |
Mar 31
| |||
Form 4
| +4.26% | 20K |
—
|
—
| 489.88K |
Dec 29
| |||
Form 4
| +12.02% | 50K |
$1.59 | $79,530.00 | 465.88K |
Nov 12
| |||
Form 4
| +13.67% | 50K |
$1.74 | $86,755.00 | 415.88K |
Aug 18 - Aug 19
| |||
Form 4
| +2.84% | 10K |
—
|
—
| 361.88K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
| +16.79% | 50K |
$2.00 | $100,015.00 | 347.88K |
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 19
| |||
Form 4
| +7.78% | 39.84K |
$2.51 | $100,000.91 | 551.78K |
Jan 29
| |||
Form 4
| +30.33% | 52.5K |
$1.91 | $100,101.75 | 225.62K |
Sep 24
| |||
Form 4
| +3.67% | 10K |
—
|
—
| 282.32K |
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
| -5.35% | -10.67K |
—
|
—
| 188.83K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| -2.26% | -4.62K |
—
|
—
| 199.5K |
Nov 29
| |||
Form 4
| +382.99% | 212.77K |
$4.70 | $1,000,000.20 | 268.32K |
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
| +16.52% | 7.35K |
$6.79 | $49,906.50 | 51.85K |
Sep 12
| |||
Form 4
| +50.85% | 15K |
$5.95 | $89,211.00 | 44.5K |
Jun 5
| |||
Form 4
| +90.24% | 12.9K |
$7.75 | $99,975.00 | 27.2K |
Mar 31
| |||
Form 4
| +2.16% | 4.31K |
$11.51 | $49,608.10 | 203.7K |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
∞
| 6.7K |
$15.09 | $101,118.00 | 6.7K |
Nov 24 - Nov 25
| |||
Form 4
|
∞
| 420 |
$16.00 | $6,720.00 | 420 |
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Paratek Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -68.63K |
—
|
—
|
0
|
Sep 21
| |||
Form 4
| -9.26% | -7.00K |
$1.90 | -$13,300.00 | 68.63K |
Scheduled
|
Feb 21
| ||
Form 4
| +35.96% | 20K |
—
|
—
| 75.63K |
Feb 8
| |||
Form 4
| +56.14% | 20K |
—
|
—
| 55.63K |
Feb 16
| |||
Form 4
| +33.80% | 9K |
—
|
—
| 35.63K |
Feb 18
| |||
Form 4
| +51.06% | 9K |
—
|
—
| 26.63K |
Feb 19
| |||
Form 4
| +74.07% | 7.5K |
—
|
—
| 17.63K |
Feb 26
| |||
Form 4
| -25.00% | -3.38K |
$7.14 | -$24,097.50 | 10.13K |
Scheduled
|
Feb 15
| ||
Form 4
| +125.00% | 7.5K |
—
|
—
| 13.5K |
Feb 14
| |||
Form 4
|
∞
| 6K |
—
|
—
| 6K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||